Gene therapy for ulcerations of the gastrointestinal tract

Drugs of Today

Volumn 42, Issue 3, 2006, Pages 193-203

  Tarnawski, Andrzej ^a,b  

^a VA LONG BEACH HEALTHCARE SYSTEM   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN 1; ANGIOPOIETIN 2; ANGIOPOIETIN RECEPTOR; COLLAGEN TYPE 1; COLLAGEN TYPE 3; CYCLOOXYGENASE 2 INHIBITOR; CYSTEINE RICH PROTEIN 61; EPHRIN; FIBROBLAST GROWTH FACTOR 1; FIBROBLAST GROWTH FACTOR 2; FIBROBLAST GROWTH FACTOR 4; GROWTH FACTOR; HEPARIN BINDING EPIDERMAL GROWTH FACTOR; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; KERATINOCYTE GROWTH FACTOR; LEPTIN; PHORBOL ESTER DERIVATIVE; PLATELET DERIVED GROWTH FACTOR; SCATTER FACTOR; TIE 1 RECEPTOR; TRANSFORMING GROWTH FACTOR ALPHA; TRANSFORMING GROWTH FACTOR BETA; TREFOIL PEPTIDE; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN; VASCULOTROPIN 165; VIRUS VECTOR;

ANGIOGENESIS; CELL MIGRATION; CELL PROLIFERATION; CHRONIC WOUND; COLITIS; CONGENITAL DISORDER; DIGESTIVE SYSTEM ULCER; DUODENUM ULCER; ENTERITIS; ESOPHAGUS ULCER; GASTROINTESTINAL TRACT; GENE EXPRESSION; GENE OVEREXPRESSION; GENE THERAPY; GRANULATION TISSUE; HISTOPATHOLOGY; HUMAN; IMMUNE RESPONSE; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PLASMID; REVIEW; SCAR FORMATION; STOMACH ULCER; TISSUE REGENERATION; ULCER HEALING; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY;

ANGIOPOIETIN-1; ANIMALS; DUODENAL ULCER; GENE THERAPY; HUMANS; PLATELET-DERIVED GROWTH FACTOR; STOMACH ULCER; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 33646257313     PISSN: 16993993     EISSN: 16994019     Source Type: Journal    
DOI: 10.1358/dot.2006.42.3.893620     Document Type: Review

References (61)

1. Tarnawski, A. Cellular and molecular mechanisms of ulcer healing. Drugs Today 1997, 33: 687.
2. Cotran, R.S., Kumar, V., Robbins, S.L. Gastric ulceration. In: Cotran, R.S., Kumar V., Robbins, S.L. (Eds.). Robbins Pathologic Basis of Disease, 5th ed. Saunders, Philadelphia 1994, 298-9, 773-7.
3. Tarnawski, A. Molecular mechanisms of ulcer healing. Drug News Perspect 2000, 13: 158-68.
4. Baatar, D., Kawanaka, H., Szabo, I.L. et al. Esophageal ulceration activates genes encoding keratinocyte growth factor and its receptor in rats: A key to esophageal ulcer healing? Gastroenterology 2002, 122: 458-68.
5. Tarnawski, A., Hollander, D., Stachura, J. et al. Vascular and microvascular changes - key factors in the development of acetic acid-induced gastric ulcers in rats. J Clin Gastroenterol 1990, 12: S148-57.
6. Clark, R.A.F. (Ed.). The Molecular and Cellular Biology of Wound Repair, 2nd ed. Plenum Press: New York 1996.
7. Martin, P. Wound healing - aiming for perfect skin regeneration. Science 1997, 276: 73-81.
8. Bennett, N.T., Schult, G.S. Growth factors and wound healing: Biochemical properties of growth factors and their receptors. Am J Surg 1993, 165: 228-37.
9. Tarnawski, A., Hollander, D., Stachura, J., Gergely, H., Krause, W.J., Sarfeh, I.J. Role of angiogenesis in healing of experimental gastric ulcer. In: Halter, F., Garner, A., Tytgat, G.N.J. (Eds.). Mechanisms of Peptic Ulcer Healing. Kluwer Academic Publisher, Boston 1991, 165-71.
10. Tarnawski, A., Stachura, J., Krause, W.J., Douglass, T.G., Gregley, H. Quality of gastric ulcer healing - a new, emerging concept. J Clin Gastroenterol 1991, 13: 542-7.
11. Tarnawski, A., Stachura, J., Durbin, T., Sarfeh, I.J., Gergely, H. Increased expression of epidermal growth factor receptor during gastric ulcer healing in rats. Gastroenterology 1992, 102: 695-8.
12. Basson, M.D., Modlin, I.M., Flynn, S.D., Jean, B.P., Madri, J.A. Independent modulation of enterocyte migration and proliferation by growth factors, matrix proteins and pharmacologic agents in an in vitro model of mucosal healing. Surgery 1992, 112: 299-308.
13. Taupin, D., Wu, D.-C., Jeon, W.-K., Devaney, K., Wang, T.C., Podolsky, D.K. The trefoil gene family are coordinately expressed immediate early genes: EGF receptor and MAP kinase-dependent interregulation. J Clin Invest 1999, 103: R31-R38.
14. Wong, W.M., Playford, R.J., Wright, N.A. Peptide gene expression in gastrointestinal mucosal ulceration: Ordered sequence or redundancy? Gut 2000, 46: 286-92.
15. Klagsbrun, M. Regulators of angiogenesis: Stimulators, inhibitors and extracellular matrix. J Cell Biochem 1991, 47: 190-200.
16. Folkman, J., Shing, Y. Angiogenesis. J Biol Chem 1992, 267: 10931-4.
17. Risau, W. Mechanisms of angiogenesis. Nature 1997, 386: 671-3.
18. Folkman, J., D'Amore, P.A. Blood vessel formation: What is its molecular basis? Cell 1996, 87: 1153-5.
19. Jones, M.K., Itani, R.M., Wang, H. et al. Activation of VEGF and Ras genes in gastric mucosa during angiogenic response to ethanol injury. Am J Physiol 1999, 276: G1345-55.
20. Jones, M.K., Wang, H., Levin, E., Itani, R.M., Sarfeh, I.J., Tarnawski, A.S. Inhibition of angiogenesis by NSAIDs. Insight into the mechanisms and implications for cancer growth and ulcer healing. Nat Med 1999, 5: 1418-23.
21. Folkman, J., Szabo, S., Stovroff, M., McNeil, P., Li, W., Sing, Y. Duodenal ulcer. Discovery of a new mechanism and development of angiogenic therapy that accelerates healing. Ann Surg 1991, 214: 414-27.
22. Szabo, S., Folkman, J., Vattay, P. et al. Accelerated healing of duodenal ulcers by oral administration of basic fibroblast growth factors in rats. Gastroenterology 1994, 106: 1106-11.
23. Szabo, S., Folkman, J., Vincze, A., Sandor, Z., Gombos, A. Modulation of vascular factors by VEGF VPF is sufficient for chronic ulcer healing and acute gastroprotection. Gastroenterology 1997, 122: A303.
24. Ferrara, N. Role of vascular endothelial growth factor in the regulation of angiogenesis. Kidney Int 1999, 56:794-814.
25. Ferrara, N., Carver, M.K., Chen, H. et al. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 1996, 380: 439-42.
26. Pedram, A., Razandi, M., Levin, E.R. Extracellular signal-regulated protein kinase/Jun kinase cross-talk underlies vascular endothelial cell growth factor-induced endothelial cell proliferation. J Biol Chem 1998, 273: 26722-8.
27. 2 receptor, by secretion-trap expression cloning. Cell 1996, 87: 1161-9.
28. Maisonpierre, P.C., Suri, C., Jones, P.F. et al. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 1997, 277: 55-60.
29. Oike, Y., Ito, Y., Hamada, K. et al. Regulation of vasculogenesis and angiogenesis by EphB/ephrin-B2 signaling between endothelial cells and surrounding mesenchymal cells. Blood 2002, 100: 1326-33.
30. Fataccioli, V., Abergel, V., Wingertsmann, L. et al. Stimulation of angiogenesis by cyr61 gene: A new therapeutic candidate. Hum Gene Ther 2002, 13: 1461-70.
31. Goetze, S., Bungenstock, A., Czupalla, C. et al. Leptin induces endothelial cell migration through Akt, which is inhibited by PPAR-gamma-ligands. Hypertension 2002, 40: 748-54.
32. Rodrigues, S., Van Aken, E., Van Bocxlaer, S. et al. Trefoil peptides as proangiogenic factors in vivo and in vitro: Implication of cyclooxygenase-2 and EGF receptor signaling. FASEB J 2003, 17: 7-16.
33. Hayes, A.J., Huang, W.Q., Mallah, J., Yang, D., Lippman, M.E., Li, L.Y. Angiopoietin-1 and its receptor Tie-2 participate in the regulation of capillary-like tubule formation and survival of endothelial cells. Microvasc Res 1999, 58: 224-37.
34. Tarnawski, A., Sekhon, S., Ichikawa, Y., Sarfeh, IJ.. Vascular endothelial growth factor (VEGF) enhances angiogenesis in injured gastric mucosa and accelerates healing of ethanol induced erosions. Gastroenterology 1998, 144: A252.
35. Szabo, S., Vincze, A., Sandor, Z. et al. Vascular approach to gastroduodenal ulceration: New studies with endothelins and VEGF. Dig Dis Sci 1998, 43 (9 Suppl.): 40S-45S.
36. Isner, J.M., Vale, P.R., Symes, J.F., Losordo, D.W. Assessment of risks associated with cardiovascular gene therapy in human subjects. Circ Res 2001, 89: 389-400.
37. Isner, J.M. Myocardial gene therapy. Nature 2002, 415: 234-9.
38. Shyu, K.G., Chang, H., Wang, B.W., Kuan, P. Intramuscular vascular endothelial growth factor gene therapy in patients with chronic critical leg ischemia. Am J Med 2003, 114: 85-92.
39. Losordo, D.W., Vale, P.R., Hendel, R.C. et al. Phase 1/2 placebo-controlled, double-blind, dose-escalating trial of myocardial vascular endothelial growth factor 2 gene transfer by catheter delivery in patients with chronic myocardial ischemia. Circulation 2002, 105: 2012-8.
40. Francis, S.C., Raizada, M.K., Mangi, A.A. et al. Genetic targeting for cardiovascular therapeutics: Are we near the summit or just beginning the climb? Physiol Genomic 2001, 7: 79-94.
41. Sylven, C. Angiogenic gene therapy. Drugs Today 2002, 38: 819-27.
42. Tyrone, J.W., Mogford, J.E., Chandler, L.A. et al. Collagen-embedded platelet-derived growth factor DNA plasmid promotes wound healing in a dermal ulcer model. J Surg Res 2000, 93: 239-6.
43. Wolff, J.A., Malone, R.W., Williams, P. et al. Direct gene transfer into mouse muscle in vivo. Science 1990, 247: 1465-8.
44. Schratzberg, P., Walter, D.H., Rittig, K. et al. Reversal of experimental diabetic neuropathy by VEGF gene transfer. J Clin Invest 2001, 107: 1083-92.
45. Szabo, S., Deng, X., Khomenko, T. et al. Gene expression and gene therapy in experimental duodenal ulceration. J Physiol 2001, 95: 325-35.
46. Deng, X., Szabo, S., Khomenko, T, Jadus, M.R., Yoshida, M. Gene therapy with adenoviral plasmids or naked DNA of vascular endothelial growth factor and platelet-derived growth factor accelerates healing of duodenal ulcer in rats. J Pharmacol Exp Ther 2004, 11: 982-8.
47. Jones, M.K., Kawanaka, H., Baatar, D. et al. Gene therapy for gastric ulcers with single local injection of naked DNA encoding VEGF and angiopoietin-1. Gastroenterology 2001, 121: 1040-7.
48. Chai, J., Baatar, D., Tarnawski, A. Serum response factor promotes re-epithelialization and muscular structure restoration during gastric ulcer healing. Gastroenterology 2004, 126: 1809-18.
49. Chai, J., Jones, M.K., Tarnawski, A.S. Serum response factor is a critical requirement for VEGF signaling in endothelial cells and VEGF-induced angiogenesis. FASEB J 2004, 18: 1264-6.
50. Baatar, D., Jones, M.K., Tsugawa, K. et al. Esophageal ulceration triggers expression of hypoxia-inducible factor-1 alpha and activates vascular endothelial growth factor gene: Implications for angiogenesis and ulcer healing. Am J Pathol 2002, 161: 1449-57.
51. Sandor, Z., Deng, X., Khomenko, T., Szabo, S. PDGF and VEGF gene therapy in experimental ulcerative colitis. Proc 30th Anniversary Congress of the Japanese Ulcer Research Society, Tokyo 2002, p. 11.
52. Li, J., Zhang, Y.P., Kirsner, R.S. Angiogenesis in wound repair: Angiogenic growth factors and the extracellular matrix. Microsc Res Tech 2003, 60: 107-14.
53. Koike, H., Morishita, R., Iguchi, S. et al. Enhanced angiogenesis and improvement of neuropathy by cotransfection of human hepatocyte growth factor and prostacyclin synthase gene. FASEB J 2003, 17: 779-81.
54. Campbell, C., Hultman, S., Cairns, B., DeSerres, S., Meyer, A. Green fluorescent protein-adenoviral construct as a model for transient gene therapy for human cultured keratinocytes in an athymic mouse model. J Trauma 2003, 54: 72-9; discussion 79-80.
55. Cutroneo, K.R., Chiu, J.F. Sense oligonucleotide competition for gene promoter binding and activation. Int J Biochem Cell Biol 2003, 35: 32-8.
56. Rogers, B., Lineaweaver, W.C. Skin wound healing and cell-mediated DNA transport. J Long Term Eff Med Implants 2002, 12: 125-30.
57. Wright, V., Peng, H., Usas, A., Young, B., Gearhart, B., Cummins, J. BMPA4-expressing muscle-derived stem cells differentiate into osteogenic lineage and improve bone healing in immunocompetent mice. Mol Ther 2002, 6: 169-78.
58. van Griensven, M., Lobenhoffer, P., Barke, A. et al. Adenoviral gene transfer in a rat fracture model. Lab Anim 2002, 36: 455-61.
59. Young, B.H., Pene, H., Huard, J. Muscle-based gene therapy and tissue engineering to improve bone healing. Clin Orthop 2002, (4j03 Suppl.): S243-51.
60. Shen, F.H., Visger, J.M., Balian, G., Hurwitz, S.R., Diduch, D.R. Systemically administered mesenchymal stroma cells transduced with insulin-like growth factor-1 localize to a fracture site and potentiate healing. J Orthop Trauma 2002, 16: 651-9.
61. Jeschke, M.G., Richter, G., Hofstadter, F., Herndon, D.N., Perez-Polo, J.R., Jauch, K.W. Non-viral liposomal keratinocyte growth factor (KGF) cDNA gene transfer improves dermal and epidermal regeneration through stimulation of epithelial and mesenchymal factors. Gene Ther 2002, 9: 1065-74.